Kazia Therapeutics Limited. Interest Expense
Kazia Therapeutics Limited. (KZIA) reported Interest Expense of AUD 7.26 thousand for the 6-month period ending 2025-12-31, per its 6-K filed 2026-03-30.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpense · last filed 2026-03-30
| Period end | Interest Expense 6 month | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | 7.26K AUD 6-K · filed 2026-03-30 | ||
| 2024-12-31 | 233.07K AUD 6-K · filed 2026-03-30 | ||
| 2023-12-31 | 259.74K AUD 6-K · filed 2025-06-10 | ||
| 2022-12-31 | 221.64K AUD 6-K · filed 2024-03-27 | ||
| 2018-06-30 | 0.00 AUD 20-F · filed 2018-10-24 | ||
| 2017-06-30 | 1.00K AUD 20-F · filed 2019-10-21 | 0.00 AUD 20-F · filed 2018-10-24 | |
| 2016-06-30 | 0.00 AUD 20-F · filed 2018-10-24 |